{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:59:12Z","timestamp":1789545552384,"version":"build-2803163510"},"reference-count":46,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6118,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1046\/j.1365-2710.1998.00185.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:32:09Z","timestamp":1047443529000},"page":"457-465","source":"Crossref","is-referenced-by-count":9,"title":["Review of management of type 2 diabetes mellitus"],"prefix":"10.1155","volume":"23","author":[{"given":"W. S.","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. T. C.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Greenaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB1|cit1","unstructured":"Kowie CC, Eberhardt MS, 1996 Diabetes 1996: Vital statistics. Alexandria, VA: American Diabetes Association."},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB2|cit2","unstructured":"Jarret RJ. 1991 The epidemiology of diabetes mellitus. In: Pickup J, Williams G, eds Textbook of Diabetes. London: Blackwell, 47."},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0025-6196(11)64841-6","article-title":"Pharmacologic treatment options for non-insulin-dependent diabetes mellitus","volume":"71","author":"Tan","year":"1996","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199200443-00005","article-title":"Management of non-insulin dependent diabetes mellitus","volume":"44","author":"Lefebvre","year":"1992","journal-title":"Drugs"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.1992.00400230129023","article-title":"Biguanide associated lactic acidosis. Case report and review of the literature","volume":"152","author":"Gan","year":"1992","journal-title":"Archives of Internal Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9343(97)89422-3","article-title":"Metformin-associated lactic acidosis","volume":"101","author":"Pearlman","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/106002809703100108","article-title":"Metformin-associated nonketotic metabolic acidosis","volume":"31","author":"Jurovich","year":"1997","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB8|cit8","first-page":"6","article-title":"Adverse Drug Reactions Advisory Committee Australian Drug Evaluation Committee.. Fatal lactic acidosis with metformin","volume":"14(2)","year":"1995","journal-title":"Australian Adverse Drug Reactions Bulletin"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB9|cit9","first-page":"612","article-title":"Metformin: a new treatment option for non-insulin-dependent diabetes mellitus","volume":"42","author":"Goo","year":"1996","journal-title":"Journal of Family Practice"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin [letter]","volume":"338","author":"Misbin","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003495-199754030-00001","article-title":"Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s: achievements and future developments","volume":"54","author":"Scheen","year":"1997","journal-title":"Drugs"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00002018-199411040-00002","article-title":"Comparative tolerability profiles of oral antidiabetic agents","volume":"11","author":"Krentz","year":"1994","journal-title":"Drug Safety"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB13|cit13","first-page":"105","article-title":"Metformin and the sulphonylureas: the comparative risk","volume":"15","author":"Campbell","year":"1985","journal-title":"Hormone and Metabolic Research Supplement"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0168-8227(91)90120-3","article-title":"Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus","volume":"14","author":"Sugarman","year":"1991","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00257338","article-title":"Glibenclamide-associated hypoglycaemia: a report on 57 cases","volume":"24","author":"Asplund","year":"1983","journal-title":"Diabetologia"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1464-5491.1995.tb00405.x","article-title":"Diabetes in the elderly","volume":"12","author":"Meneilly","year":"1995","journal-title":"Diabetic Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/diacare.17.2.142","article-title":"Slow elimination of glyburide in NIDDM subjects","volume":"17","author":"Jonsson","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.17.9.1026","article-title":"Hypoglycemic activity of glyburide (glibenclamide) metabolites in man","volume":"17","author":"Rydberg","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB19|cit19","doi-asserted-by":"crossref","unstructured":"Ferner RE, Neil HA. 1988 Sulphonylurea and hypoglycaemia British Medical Journal 296 949","DOI":"10.1136\/bmj.296.6627.949"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8529(18)30395-5","article-title":"Drug-induced hypoglycemia. A review of 1418 cases","volume":"18","author":"Seltzer","year":"1989","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.12.3.203","article-title":"Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents","volume":"12","author":"Jennings","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1464-5491.1993.tb00039.x","article-title":"Hypoglycaemic admissions among diabetic patients in Soweto, South Africa","volume":"10","author":"Gill","year":"1993","journal-title":"Diabetic Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1464-5491.1994.tb00256.x","article-title":"Glibenclamide vs gliclazide in type 2 diabetes of the elderly","volume":"11","author":"Tessier","year":"1994","journal-title":"Diabetic Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB24|cit24","first-page":"186","article-title":"Anti-diabetic drugs as a cause of hypoglycaemia among acute medical admissions in Hong Kong and Singapore - relationship to the prescribing patterns in diabetic patients","volume":"39","author":"Chan","year":"1998","journal-title":"Singapore Medical Journal"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB25|cit25","unstructured":"Melander A 1990 Treatment with oral antidiabetic agents. In: Strandberg K, Beermann B, Lonnerholm G, eds Treatment of Non-Insulin-Dependent Diabetes Mellitus. Uppsala, Sweden: Swedish Medical Products Agency 87 114"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/diacare.15.1.75","article-title":"Benefits and risks with glyburide and glipizide in elderly NIDDM patients","volume":"15","author":"Brodows","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/0168-8227(91)90010-B","article-title":"Efficacy of gliclazide in comparison with other sulfonylureas in the treatment of NIDDM","volume":"14 (Suppl. 2)","author":"Harrower","year":"1991","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2165\/00003495-199346010-00007","article-title":"Gliclazide: an update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus","volume":"46","author":"Palmer","year":"1993","journal-title":"Drugs"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8727(94)90044-2","article-title":"Comparison of efficacy, secondary failure rate, and complications of sulfonylureas","volume":"8","author":"Harrower","year":"1994","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB31|cit31","unstructured":"Thomas J. 1996 Australian Prescription Products Guide 1996, 25th edn. Melbourne, Victoria: Australian Pharmaceutical Publishing Company Ltd."},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB33|cit33","unstructured":"1997 Therapeutic Guidelines Endocrinology Writing Group. Therapeutic Guidelines: Endocrinology. Melbourne: Therapeutic Guidelines Limited."},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study 33: intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study 34: effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patients","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomised prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002280050285","article-title":"Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - change over time","volume":"52","author":"Wandell","year":"1997","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2337\/diacare.11.7.558","article-title":"Trends in use of oral hypoglycemic agents 1964-86","volume":"11","author":"Kennedy","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB39|cit39","first-page":"169","article-title":"Drug therapy in patients with diabetes mellitus: an audit","volume":"12","author":"Paterson","year":"1989","journal-title":"Diabetes Research"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB40|cit40","first-page":"19","article-title":"Biguanide- related lactic acidosis: incidence and risk factors","volume":"23","author":"Aguilar","year":"1992","journal-title":"Archives of Medical Research"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.20.6.925","article-title":"Contraindications to metformin therapy in patients with NIDDM","volume":"20","author":"Sulkin","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003495-199549050-00007","article-title":"Metformin: a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus","volume":"49","author":"Dunn","year":"1995","journal-title":"Drugs"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB43|cit43","first-page":"547","article-title":"Pharmacological treatment of the obese diabetic patient","volume":"19","author":"Scheen","year":"1993","journal-title":"Diabetes and Metabolism"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-118-3-199302010-00002","article-title":"What is the benefit of increasing the sulfonylurea dose?","volume":"118","author":"Stenman","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/0168-8227(95)01077-Q","article-title":"Insulin therapy in type II diabetes","volume":"28 (Supplement)","author":"Holman","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1046\/j.1365-2710.1998.00185.x-BIB46|cit46","first-page":"6","article-title":"New oral antihyperglycaemic agents expand armamentarium in the battle against type 2 diabetes mellitus.","volume":"12 (7)","author":"Anon.","year":"1998","journal-title":"Drugs and Therapy Perspectives"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2710.1998.00185.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2710.1998.00185.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:04Z","timestamp":1671818524000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1046\/j.1365-2710.1998.00185.x"}},"subtitle":["Review of type 2 diabetes management"],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2710.1998.00185.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}